Intervention
ultrasound imaging
ClinicalTrials.gov intervention label
Clinical trials
15 shownVascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After SurgeryNCT01483196 · 2012-01-01
COMPLETEDTransrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic SurgeryNCT01495130 · 2011-10-01
COMPLETEDDutasteride in Treating Patients With Prostate CancerNCT01193855 · 2010-06-01
UNKNOWNSurgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerNCT00881361 · 2009-07-01
COMPLETEDRadiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the BreastNCT00602628 · 2007-11-01
COMPLETEDMRI in Assessing Tumor Size in Women With Ductal Carcinoma In SituNCT00874458 · 2007-04-01
COMPLETEDIncidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsNCT00433602 · 2006-11-01
COMPLETEDUltrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast SonographyNCT01681901 · 2006-06-07
WITHDRAWNBiomarkers in Patients Undergoing Transrectal Ultrasound Prostate BiopsyNCT00373035 · 2006-02-01
COMPLETEDEverolimus and Vatalanib in Treating Patients With Advanced Solid TumorsNCT00655655 · 2004-12-01
COMPLETEDBiomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryNCT00665457 · 2004-04-15
TERMINATEDBreast Ultrasound and Mammography in Screening Women at High Risk for Breast CancerNCT00072501 · 2004-04-01
COMPLETEDComputed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate CancerNCT00084526 · 2003-11-01
COMPLETEDDiagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer SurgeryNCT00033397 · 2002-02-01
COMPLETEDEnhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast CancerNCT00005058 · 1997-08-01
UNKNOWNCommon conditions
Breast Cancer9Prostate Cancer5Cognitive/Functional Effects1Colorectal Cancer1Gastric Cancer1Gastrinoma1Glucagonoma1Insulinoma1Lung Cancer1Metastatic Gastrointestinal Carcinoid Tumor1Metastatic Pheochromocytoma1Ovarian Cancer1Pancreatic Cancer1Pancreatic Polypeptide Tumor1Recurrent Breast Cancer1Recurrent Gastrointestinal Carcinoid Tumor1Recurrent Islet Cell Carcinoma1Recurrent Melanoma1Recurrent Neuroendocrine Carcinoma of the Skin1Recurrent Non-small Cell Lung Cancer1Recurrent Pheochromocytoma1Recurrent Renal Cell Cancer1Somatostatinoma1Stage IA Breast Cancer1Stage IB Breast Cancer1
Leading sponsors
Alliance for Clinical Trials in Oncology2Royal Marsden NHS Foundation Trust2Wake Forest University Health Sciences2American College of Radiology Imaging Network1Centre Antoine Lacassagne1European Organisation for Research and Treatment of Cancer - EORTC1Fox Chase Cancer Center1Mayo Clinic1Ohio State University Comprehensive Cancer Center1University College London Hospitals1University of Nebraska1University of Southern California1
Trial status mix
COMPLETED11
UNKNOWN2
TERMINATED1
WITHDRAWN1
Phase mix
NA6
PHASE24
PHASE12
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.